UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: 9/30/02
-----------------------
Check Here if Amendment / /; Amendment Number:
---------
This Amendment (Check only one.): / / is a restatement.
/ / adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Hambrecht & Quist Capital Management LLC
-----------------------------------------
Address: 30 Rowes Wharf
-----------------------------------------
Boston, MA 02110
-----------------------------------------
-----------------------------------------
Form 13F File Number: 28-04219
---------------------
The institutional investment manager filing this report and the person by
whom it is signed hereby represent that the person signing the report is
authorized to submit it, that all information contained herein is true,
correct and complete, and that it is understood that all required items,
statements, schedules, lists, and tables, are considered integral parts of
this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kim Carroll
-------------------------------
Title: Treasurer
-------------------------------
Phone: 617-772-8525
-------------------------------
Signature, Place, and Date of Signing:
Kim Carroll Boston, MA 10/18/02
------------------------------- ----------------- -------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
/X/ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
/ / 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s).)
/ / 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
------------------------------------------------------------------------------------------------------------------------------------
ITEM 6:
INVESTMENT DISCRETION
(b)
SHARED- ITEM 8:
AS ITEM 7: VOTING
ITEM 2: ITEM 4: ITEM 5: DEFINED MANAGERS AUTHORITY
TITLE ITEM 3: FAIR SHARES OF IN (c) SEE (SHARES)
ITEM 1: OF CUSIP MARKET PRINCIPAL (a) INSTR. SHARED- INSTR. (a) (b) (c)
NAME OF ISSUER CLASS NUMBER VALUE AMOUNT SOLE V OTHER V SOLE SHARED NONE
------------------------------------------------------------------------------------------------------------------------------------
Abgenix Common 00039B107 $3,212,550 495,000 X NA X
Adolor Common 00724X102 $7,263,762 518,100 X NA X
Aradigm Common 038505103 735,000 350,000 X NA X
Biofield Common 090591207 351,547 878,866 X NA X
Biofield (Restricted) Common 090591207 320,000 1,000,000 X NA X
Biopure Common 09065H915 594,111 169,746 X NA X
BioTransplant Common 09066Y107 1,239,782 712,518 X NA X
Catalytica Energy Systems Common 148884109 445,947 128,515 X NA X
Celgene Common 151020104 11,619,600 690,000 X NA X
Cephalon Common 156708109 3,673,800 90,000 X NA X
Corixa Common 21887F100 4,536,059 716,597 X NA X
Cubist Pharmaceuticals Common 229990981 4,895,405 958,005 X NA X
CV Therapeutics Common 126667104 11,423,279 546,307 X NA X
Cytyc Common 232946103 4,655,546 434,286 X NA X
deCODE Genetics Common 24386104 1,639,000 745,000 X NA X
Digene Common 253752109 217,250 27,500 X NA X
Dyax Common 26746E103 1,346,874 694,265 X NA X
Endocardial Solutions Common 292962107 5,383,331 1,666,666 X NA X
Endologix Common 292665106 330,000 330,000 X NA X
Envirogen Common 294040100 11,250 20,833 X NA X
EP MedSystems Common 26881P103 2,150,000 1,075,000 X NA X
Exelixis Common 30161Q104 6,048,900 1,222,000 X NA X
Genzyme Common 372917104 5,544,090 269,000 X NA X
Gilead Sciences Common 37555B103 24,364,105 726,636 X NA X
IDEXX Laboratories Common 45168D104 7,737,000 250,000 X NA X
IVAX Common 465823102 4,392,660 358,000 X NA X
Lexicon Genetics Common 288872104 743,855 185,500 X NA X
Lynx Therapeutics Common 551812308 1,349,800 1,985,000 X NA X
Martek Biosciences Common 572901106 12,780,069 780,224 X NA X
MedImmune Common 584699102 6,903,600 330,000 X NA X
Molecular Devices Common 60851C107 3,637,508 290,768 X NA X
Orthovita Common 68750U102 4,675,000 1,700,000 X NA X
Quintiles Transnational Common 748767100 1,454,079 152,900 X NA X
Rigel Pharmaceuticals Common 766559108 1,644,000 1,027,500 X NA X
Telik Common 87959M109 8,253,313 666,665 X NA X
Teva Pharmaceutical Industries Common 881624209 6,700,000 100,000 X NA X
Transkaryotic Therapies Common 893735100 12,398,446 382,550 X NA X
Tularik Common 899165104 2,777,025 405,405 X NA X
Versicor Common 925314106 5,937,938 696,941 X NA X
Vertex Pharmaceuticals Common 92532F100 3,507,553 189,700 X NA X
WebMD Common 94769M105 3,825,375 757,500 X NA X
COLUMN TOTALS $190,718,409